Skip to main content

Oxford Cannabinoid Technologies "proceeding forward as planned" after review meeting

Oxford Cannabinoid Technologies Holdings PLC (LSE:OCTP, OTCQB:OCTHF) CEO Clarissa Sowemimo-Coker speaks to Proactive after announcing that a Research Ethics Committee (REC) review meeting for its lead programme OCT461201 has now taken place. Sowemimo-Coker says the company is "proceeding forward as planned" and has "hit the ground running" in 2023.

Contact Details

Proactive UK Ltd

+44 20 7989 0813

uk@proactiveinvestors.com

Recent Quotes

View More
Symbol Price Change (%)
AMZN  254.98
+10.76 (4.41%)
AAPL  267.85
-2.52 (-0.93%)
AMD  256.45
+0.33 (0.13%)
BAC  53.09
-0.36 (-0.66%)
GOOG  283.43
+1.61 (0.57%)
META  651.07
+2.72 (0.42%)
MSFT  517.99
+0.18 (0.03%)
NVDA  208.04
+5.55 (2.74%)
ORCL  257.44
-5.17 (-1.97%)
TSLA  465.63
+9.07 (1.99%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.